1. PI3K/Akt/mTOR Apoptosis Epigenetics Cell Cycle/DNA Damage Stem Cell/Wnt
  2. Akt Apoptosis Caspase PARP β-catenin
  3. AKT-IN-28

AKT-IN-28 is an Akt allosteric inhibitor, a derivative of Shikonin (HY-N0822). AKT-IN-28 effectively binds to the allosteric site of Akt through hydrophobic and hydrogen interactions with Kd of 2.07 μM. AKT-IN-28 significantly inhibits Akt activity, induces cell apoptosis, arrests cell cycle in G2/M phase, and suppresses proliferation, migration and metabolism of KRAS mutant colorectal cancer cells.

For research use only. We do not sell to patients.

AKT-IN-28 Chemical Structure

AKT-IN-28 Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

AKT-IN-28 is an Akt allosteric inhibitor, a derivative of Shikonin (HY-N0822). AKT-IN-28 effectively binds to the allosteric site of Akt through hydrophobic and hydrogen interactions with Kd of 2.07 μM. AKT-IN-28 significantly inhibits Akt activity, induces cell apoptosis, arrests cell cycle in G2/M phase, and suppresses proliferation, migration and metabolism of KRAS mutant colorectal cancer cells[1].

IC50 & Target

Caspase 3

 

PARP

 

Akt

2.07 μM (Kd)

In Vitro

AKT-IN-28 (Compound L8) has a potent anti-proliferative activity (IC50 s of 4.51, 4.57, 5.07, 8.94 and 6.59 μM for HCT-8, HCT-116, PC-3, MDA-MB-231, and HeLa cells, respectively), with low cytotoxicity in normal cells (IC50 s of > 100  and 67 μM for MCF-10A and HCoEpiC cells)[1].
AKT-IN-28 (1-4 μM, 24 h) dose-dependently decreases the Akt enzyme activity, and significantly inhibits the total Akt, p-Akt, PARP and β-catenin protein expression, cell proliferation activity and migration, while increase of cleaved-PARP protein level in HCT-8 and HCT-116 cells[1].
AKT-IN-28 (0.25-1 μM, 7 days) significantly inhibites the viability of colon cancer cells with reduction of colony formation of HCT-116 cells[1].
AKT-IN-28 (2-8 μM, 24 h) effectively induces cell apoptosis and arrests cell cycle in G2/M phase (8 μM) with decrease of cycle-related proteins CDH1, CDK1, and CDC20, and increases caspase3 activity in HCT-116 and HCT-8 cells[1].
AKT-IN-28 (2-8 μM, 2-24 h) significantly reduces the glucose consumption, lactate production, and ATP level in HCT-116 cells[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Proliferation Assay[1]

Cell Line: HCT-116 cells
Concentration: 1, 2, 4 μM
Incubation Time: 24 h
Result: Significantly reduced the percentage of EdU-positive cells.

Cell Migration Assay [1]

Cell Line: HCT-8 cells, HCT-116 cells
Concentration: 1, 2, 4 μM
Incubation Time: 3, 6, 12, 24 h
Result: Significantly reduced the number of metastasis colon cancer cells and enlarged the space area of migrating cells.

Western Blot Analysis[1]

Cell Line: HCT-116 cells
Concentration: 1, 2, 4 μM
Incubation Time: 24 h
Result: Significantly inhibited the total Akt, p-Akt, PARP and β-catenin protein expression but increased cleaved-PARP protein level.
Obviously decreased the expression levels of cycle-related proteins CDH1, CDK1, and CDC20.

Cell Cycle Analysis[1]

Cell Line: HCT-8 cells, HCT-116 cells
Concentration: 2, 4, 8 μM
Incubation Time: 24 h
Result: Arrested the cell cycle at G2/M phase at 8 μM in HCT-8 and HCT-116 cells.

Apoptosis Analysis[1]

Cell Line: HCT-8 cells, HCT-116 cells
Concentration: 2, 4, 8 μM
Incubation Time: 24 h
Result: Effectively induced cell apoptosis in HCT-8 and HCT-116 cells.
Molecular Weight

573.57

Formula

C32H28FNO8

SMILES

OC1=CC=C(O)C2=C1C(C=C(C(OC(CC3=CC=C(NC(COC4=CC=C(F)C=C4)=O)C=C3)=O)C/C=C(C)\C)C2=O)=O

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
AKT-IN-28
Cat. No.:
HY-174254
Quantity:
MCE Japan Authorized Agent: